AbbVie leukemia drug impresses in early-stage trial

[Reuters] – An experimental AbbVie Inc drug for leukemia controlled or eliminated signs of the disease in more than 80 percent of patients who had failed to benefit from previous treatments, an unprecedented finding that could spur use of the medicine fo more

View todays social media effects on ABBV

View the latest stocks trending across Twitter. Click to view dashboard